Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
67.60    2.20 (3.36%)
Bid:
65.60
Ask:
70.00
Spread: 4.40 (6.707%)
Market Cap: £91.24m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMR Shareholding

12 Sep 2024 16:21

RNS Number : 0208E
Trifast PLC
12 September 2024
 

 

Thursday, 12 September 2024

 

Trifast plc

(the "Company")

 

Notification and public disclosure of transactions by PDMR

 

The Company announces that, further to the terms set out in the Company's Directors' Remuneration Policy ("Policy") and the Trifast plc Executive Turnaround Plan ("Turnaround Plan"), both of which were approved at the AGM on 10 September 2024, the Remuneration Committee ("Committee") granted options to each of Iain Percival and Kate Ferguson over the number of ordinary shares of 5p each in the Company ("Ordinary Shares") as set out in the table below under the terms of the rules of the Turnaround Plan ("Rules"). The options were granted on 10 September 2024 with an exercise price of £0.8056 per Ordinary Share, being the average share price over the five business days immediately before the date of grant.

 

PDMR

Number of Ordinary Shares

over which options granted

Equivalent percentage of issued share capital

Iain Percival

2,994,522

2.2%

Kate Ferguson

1,769,490

1.3%

 

1 74,478 Ordinary Shares placed under option to each PDMR were granted in the form of a CSOP option.

 

As set out in the Company's RNS announcement of 27 August 2024, and subject to the Rules, the options will vest subject to a performance target relating to the achievement of share price hurdles relating to the Ordinary Shares and become exercisable subject to any adjustment made through the application of a performance underpin. Vested options will become exercisable on a staggered basis on the 3rd, 4th and 5th anniversaries of the date of grant.

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

 

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Iain Percival

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of

transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument Identification code

Ordinary shares of 5 pence each

 

GB0008883927

b.

Nature of the transaction

Grant of option under the Trifast plc Executive Turnaround Plan

c.

Price(s) and volume(s)

Price(s) 

Volume(s)

£0.8056

2,920,044

d.

Aggregated information

·Aggregated volume

·Price

 

2,920,044

£0.8056

e.

Date of the transaction

10.09.24

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Iain Percival

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of

transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument Identification code

Ordinary shares of 5 pence each

 

GB0008883927

b.

Nature of the transaction

Grant of CSOP option under the Trifast plc Executive Turnaround

Plan

c.

Price(s) and volume(s)

Price(s) 

Volume(s)

£0.8056

74,478

d.

Aggregated information

·Aggregated volume

·Price

 

74,478

£0.8056

e.

Date of the transaction

10.09.24

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kate Ferguson

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of

transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument Identification code

Ordinary shares of 5 pence each

 

GB0008883927

b.

Nature of the transaction

Grant of option under the Trifast plc Executive Turnaround Plan

c.

Price(s) and volume(s)

Price(s) 

Volume(s)

£0.8056

1,695,012

d.

Aggregated information

·Aggregated volume

·Price

 

1,695,012

£0.8056

e.

Date of the transaction

10.09.24

f.

Place of the transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kate Ferguson

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of

transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument Identification code

Ordinary shares of 5 pence each

 

GB0008883927

b.

Nature of the transaction

Grant of CSOP option under the Trifast plc Executive Turnaround

Plan

c.

Price(s) and volume(s)

Price(s) 

Volume(s)

£0.8056

74,478

d.

Aggregated information

·Aggregated volume

·Price

 

74,478

£0.8056

e.

Date of the transaction

10.09.24

f.

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGMLKZGGDZM
Date   Source Headline
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.